Register to leave comments

  • News bot May 6, 2026, 8:27 p.m.

    📋 TENAYA THERAPEUTICS, INC. (TNYA) - Financial Results

    Filing Date: 2026-05-06

    Accepted: 2026-05-06 16:11:42

    Event Type: Financial Results

    Event Details:

    TENAYA THERAPEUTICS, INC. (TNYA) Reports the reporting period Financial Results TENAYA THERAPEUTICS, INC. (TNYA) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 225
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 80887
      • Expected in the Second Quarter 2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Operating Expenses Loss From Operations 20.07K 27.54K $-7.47K -27.14%
    Other Income Net Interest Income 793.00 635.00 $158.00 +24.88%
    Income Tax Expense Net Loss 19.27K 26.86K $-7.59K -28.26%
    Income Tax Expense Net Loss Per Share 0.09 0.24 $-0.15 -62.50%
    Income Tax Expense Weighted Average Shares 216.88M 109.87M $107.01M +97.40%
    Loss from Operations 20.07K 27.54K $-7.47K -27.14%
    Interest Income 793.00 635.00 $158.00 +24.88%
    Other Income, Net 793.00 674.00 $119.00 +17.66%
    Net Loss 19.27K 26.86K $-7.59K -28.26%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: TENAYA THERAPEUTICS, INC.
    • Ticker Symbol: TNYA